Clinical Trial

Impact of Long-acting Bronchodilator- -Corticoid Inhaled Therapy on Ventilation, Lung Function and Breathlessness

Study acronym: VARI-OSCIL
Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
Multicentre, prospective, non-randomised, single-arm, open label, mechanistic study to investigate the mechanism of action of BGF 160 on ventilation pattern complexity and variability
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-10-30.
Trial Details
NCT Number NCT06110403
Lead Sponsor University Hospital, Lille
Collaborators: AstraZeneca
Conditions Copd
Enrollment 35 participants
Start Date 2023-09-29
Primary Completion 2026-09 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2025-12-18